Seeking Alpha

The Sprint (S) board schedules a noon phone meeting to discuss the possibility of renewing its...

The Sprint (S) board schedules a noon phone meeting to discuss the possibility of renewing its pursuit of Metro PCS (PCS), say sources. When the board rejected what looked like a sealed deal for MetroPCS in February, Sprint's stock was just $2/share, but after a rally to $5, progress on the network upgrade, and the iPhone investment paying off, directors may have a change in attitude.
Comments (5)
  • titans
    , contributor
    Comments (193) | Send Message
     
    sell,sell,sell. Pump & dump in play. Run stock up with this news, then dump after investors but S shares. This game will go on for months with this stock. Too many other stocks to choose from.
    5 Oct 2012, 09:52 AM Reply Like
  • Headcoach
    , contributor
    Comments (431) | Send Message
     
    LOLOLOL....nice. Yeah, I dough you are going to find a stock like this that will provide you the type of increases you have been getting. Okay, maybe one other....Clearwire. But I don't expect big results here until the end of the month when they come out with their Q3. But for the last several Q reports, they have been coming out of the hole. So I expect good results this month.

     

    As for your sell,sell, sell. Please do it now, so I can buy it...thank you.
    5 Oct 2012, 10:55 AM Reply Like
  • fent623
    , contributor
    Comments (5) | Send Message
     
    I agree & will jump you to buy it myself.
    5 Oct 2012, 11:19 AM Reply Like
  • fent623
    , contributor
    Comments (5) | Send Message
     
    I agree & will jump you for Titans stock...
    5 Oct 2012, 11:30 AM Reply Like
  • Moosh
    , contributor
    Comments (125) | Send Message
     
    I'll see Sprint $7 in 2012.
    6 Oct 2012, 12:57 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|